MCC950, a selective NLPR3 inflammasome inhibitor, improves neurologic function and survival after cardiac arrest and resuscitation
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MCC950, a selective NLPR3 inflammasome inhibitor, improves neurologic function and survival after cardiac arrest and resuscitation
Authors
Keywords
-
Journal
Journal of Neuroinflammation
Volume 17, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-08-31
DOI
10.1186/s12974-020-01933-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
- (2020) Salim S. Virani et al. CIRCULATION
- PERK (Protein Kinase RNA-Like ER Kinase) Branch of the Unfolded Protein Response Confers Neuroprotection in Ischemic Stroke by Suppressing Protein Synthesis
- (2020) Ya-chao Wang et al. STROKE
- Cardiac arrest and resuscitation activates the hypothalamic-pituitary-adrenal axis and results in severe immunosuppression
- (2020) Qiang Zhao et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- The post-cardiac arrest syndrome: A case for lung–brain coupling and opportunities for neuroprotection
- (2019) Nguyen Mai et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition
- (2019) Rebecca C. Coll et al. Nature Chemical Biology
- NLRP3 inflammasome as a potential treatment in ischemic stroke concomitant with diabetes
- (2019) Pu Hong et al. Journal of Neuroinflammation
- CA1-projecting subiculum neurons facilitate object–place learning
- (2019) Yanjun Sun et al. NATURE NEUROSCIENCE
- Emerging Activators and Regulators of Inflammasomes and Pyroptosis
- (2019) Yansong Xue et al. TRENDS IN IMMUNOLOGY
- Hypothermia Inhibits Cerebral Necroptosis and NOD-Like Receptor Pyrin Domain Containing 3 Pathway in a Swine Model of Cardiac Arrest
- (2019) Anyu Qian et al. JOURNAL OF SURGICAL RESEARCH
- MCC950, the Selective Inhibitor of Nucleotide Oligomerization Domain-Like Receptor Protein-3 Inflammasome, Protects Mice against Traumatic Brain Injury
- (2018) Saifudeen Ismael et al. JOURNAL OF NEUROTRAUMA
- Out-of-hospital cardiac arrest: in-hospital intervention strategies
- (2018) Christian Hassager et al. LANCET
- Ozone protects the rat lung from ischemia-reperfusion injury by attenuating NLRP3-mediated inflammation, enhancing Nrf2 antioxidant activity and inhibiting apoptosis
- (2018) Zhiwen Wang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Targeting the NLRP3 inflammasome in inflammatory diseases
- (2018) Matthew S. J. Mangan et al. NATURE REVIEWS DRUG DISCOVERY
- Aging Is Associated With Impaired Activation of Protein Homeostasis‐Related Pathways After Cardiac Arrest in Mice
- (2018) Yuntian Shen et al. Journal of the American Heart Association
- The NLRP3 inflammasome in acute myocardial infarction
- (2017) Stefano Toldo et al. Nature Reviews Cardiology
- Early Effects of Prolonged Cardiac Arrest and Ischemic Postconditioning during Cardiopulmonary Resuscitation on Cardiac and Brain Mitochondrial Function in Pigs
- (2017) Timothy R. Matsuura et al. RESUSCITATION
- Selective NLRP3 (Pyrin Domain–Containing Protein 3) Inflammasome Inhibitor Reduces Brain Injury After Intracerebral Hemorrhage
- (2017) Honglei Ren et al. STROKE
- Extracellular ATP Activates the NLRP3 Inflammasome and Is an Early Danger Signal of Skin Allograft Rejection
- (2017) Joaquín Amores-Iniesta et al. Cell Reports
- The Involvement of Danger-Associated Molecular Patterns in the Development of Immunoparalysis in Cardiac Arrest Patients
- (2015) Kim Timmermans et al. CRITICAL CARE MEDICINE
- A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
- (2015) Rebecca C Coll et al. NATURE MEDICINE
- AIM2 and NLRC4 inflammasomes contribute with ASC to acute brain injury independently of NLRP3
- (2015) Adam Denes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- NLRP3 Deficiency Ameliorates Neurovascular Damage in Experimental Ischemic Stroke
- (2014) Fan Yang et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Inflammasomes in the CNS
- (2014) John G. Walsh et al. NATURE REVIEWS NEUROSCIENCE
- New Insights into Mechanisms Controlling the NLRP3 Inflammasome and Its Role in Lung Disease
- (2013) Dominic De Nardo et al. AMERICAN JOURNAL OF PATHOLOGY
- K+ Efflux Is the Common Trigger of NLRP3 Inflammasome Activation by Bacterial Toxins and Particulate Matter
- (2013) Raúl Muñoz-Planillo et al. IMMUNITY
- Inflammasomes in liver diseases
- (2012) Gyongyi Szabo et al. JOURNAL OF HEPATOLOGY
- Critical role for calcium mobilization in activation of the NLRP3 inflammasome
- (2012) T. Murakami et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibition of lymphocyte trafficking shields the brain against deleterious neuroinflammation after stroke
- (2011) Arthur Liesz et al. BRAIN
- Cutting Edge: Reactive Oxygen Species Inhibitors Block Priming, but Not Activation, of the NLRP3 Inflammasome
- (2011) F. Bauernfeind et al. JOURNAL OF IMMUNOLOGY
- The Inflammasomes in Kidney Disease
- (2011) H.-J. Anders et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Cutting Edge: NF- B Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression
- (2009) F. G. Bauernfeind et al. JOURNAL OF IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started